Spruce Biosciences Stock Investor Sentiment

SPRB Stock  USD 0.39  0.01  2.63%   
About 58% of all Spruce Biosciences' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Spruce Biosciences suggests that some traders are interested. The current market sentiment, together with Spruce Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Spruce Biosciences stock news signals to limit their universe of possible portfolio assets.
  

Spruce Biosciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Spruce Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
62.1%
54.0%
55.3%
56.0%
53.8%
60.2%
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a week ago at zacks.com         
NeoGenomics Tops Q4 Earnings Estimates
zacks News
over a week ago at kalkinemedia.com         
Spruce Biosciences Navigating Market Dynamics Amid Clinical Progress
news
over two weeks ago at thelincolnianonline.com         
Spruce Biosciences, Inc. Given Average Recommendation of Hold by Brokerages
news
over a month ago at thelincolnianonline.com         
Spruce Biosciences, Inc. Receives Consensus Rating of Hold from Analysts
news
over a month ago at www.macroaxis.com         
Acquisition by Gharib Samir M. of 308000 shares of Spruce Biosciences subject to Rule 16b-3
Macroaxis News
over a month ago at thelincolnianonline.com         
Short Interest in Spruce Biosciences, Inc. Drops By 51.1
news
over two months ago at thelincolnianonline.com         
Spruce Biosciences, Inc. Receives 3.90 Consensus Target Price from Brokerages
news
over two months ago at thelincolnianonline.com         
Short Interest in Spruce Biosciences, Inc. Rises By 613.4
news
over two months ago at investing.com         
Spruce Biosciences names new interim CMO
Investing News at Macroaxis
over two months ago at news.google.com         
Spruce Biosciences Appoints Interim Chief Medical Officer - TipRanks
Google News at Macroaxis
over two months ago at www.macroaxis.com         
Disposition of 32005 shares by Szwarcberg Javier B. of Spruce Biosciences at 0.3887 subject to Rule ...
Macroaxis News
over two months ago at thelincolnianonline.com         
Spruce Biosciences Neutral Rating Reiterated at HC Wainwright
news
over two months ago at www.macroaxis.com         
Disposition of 111000 shares by Szwarcberg Javier B. of Spruce Biosciences subject to Rule 16b-3
Macroaxis News
over two months ago at zacks.com         
Spruce Biosciences Upgraded to Buy Heres Why
zacks News
over two months ago at thelincolnianonline.com         
Spruce Biosciences Sector Perform Rating Reaffirmed at Royal Bank of Canada
news
Far too much social signal, news, headlines, and media speculation about Spruce Biosciences that are available to investors today. That information is available publicly through Spruce media outlets and privately through word of mouth or via Spruce internal channels. However, regardless of the origin, that massive amount of Spruce data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Spruce Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Spruce Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Spruce Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Spruce Biosciences alpha.

Spruce Biosciences Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.15123456789Dec2025Feb -20-10010
JavaScript chart by amCharts 3.21.15Spruce Biosciences Spruce Biosciences Dividend Benchmark Dow Jones Industrial
       Timeline  
1
Spruce Biosciences stock holds potential as Oppenheimer targets upcoming Phase 2b results
12/02/2024
2
Disposition of 128020 shares by Szwarcberg Javier B. of Spruce Biosciences at 0.537 subject to Rule 16b-3
12/10/2024
3
Oppenheimer cuts Spruce Biosciences to perform
12/11/2024
4
Disposition of 111000 shares by Szwarcberg Javier B. of Spruce Biosciences subject to Rule 16b-3
12/16/2024
5
Disposition of 32005 shares by Szwarcberg Javier B. of Spruce Biosciences at 0.3887 subject to Rule 16b-3
12/20/2024
6
Spruce Biosciences Appoints Interim Chief Medical Officer - TipRanks
12/27/2024
7
Spruce Biosciences, Inc. Receives 3.90 Consensus Target Price from Brokerages
12/31/2024
8
Acquisition by Gharib Samir M. of 308000 shares of Spruce Biosciences subject to Rule 16b-3
01/17/2025
9
NeoGenomics Tops Q4 Earnings Estimates
02/18/2025

Complementary Tools for Spruce Stock analysis

When running Spruce Biosciences' price analysis, check to measure Spruce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spruce Biosciences is operating at the current time. Most of Spruce Biosciences' value examination focuses on studying past and present price action to predict the probability of Spruce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spruce Biosciences' price. Additionally, you may evaluate how the addition of Spruce Biosciences to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
News Freq…Investor S…